SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-07-17
👔
Akari Therapeutics Plc
@AKTX_InsiderForm 4 Filing: Patel Samir Rashmikant Exercises Options for $9,680.506 of $AKTX
OPTION EXERCISE
⚡ MATERIALITY: 3/10
corporate issuer
Akari Therapeutics Plc
Ticker: $AKTX
Transaction Value
$9,680.506
Price/Share: $0.43
transaction date
2026-07-07
Shares: 22,474
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Patel Samir Rashmikant, holds the title of Director at Akari Therapeutics Plc.
On 2026-07-07, the insider transacted 22,474 shares.The shares were transacted at a weighted average price of $0.43 per share, resulting in a total market-relevant value of $9,680.506.
Executive Summary Summary
Patel Samir Rashmikant (Director) exercised options for $10K of $AKTX
Post-Transaction Position: 76,976 shares
SEC Accession No: 0001493152-26-033634 (CIK: 1702447)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.